Athanor Capital, LP Vbi Vaccines Inc Transaction History

Athanor Capital, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$2.91 - $4.32 $185,433 - $275,283	-63,723 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$2.15 - $3.5 $55,579 - $90,478	-25,851 Reduced 28.86%	63,723 $175,000
Q3 2020 Nov 16, 2020	SELL	$2.77 - $6.17 $104,703 - $233,219	-37,799 Reduced 29.68%	89,574 $256,000
Q2 2020 Aug 13, 2020	BUY	$0.87 - $3.13 $110,814 - $398,677	127,373 New	127,373 $395,000
Q1 2020 May 14, 2020	SELL	$0.73 - $1.91 $85,281 - $223,133	-116,824 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$0.48 - $1.38 $56,075 - $161,217	116,824 New	116,824 $161,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Athanor Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Athanor Capital, LP with notifications on news.